Saturday 17 October 2026
Export VOR’s income statement to Excel — free account
Vor Biopharma Inc.
18.03
1.31
−6.77%
Follow VOR
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 0.12 | 3.45 | 4.81 | 21.12 | 18.06 | — | — | — |
Net Debt/EBITDA |
— | (1.24) | 0.63 | 0.72 | 2.93 | 2.27 | — | — | — |
Debt/Assets |
0.00% | 442.80% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | (0.66) | 0.00 | 0.38 | 0.08 | 0.16 | — | — | — |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.64 | 0.78 | 0.84 | 1.00 | 0.92 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Interest Coverage |
— | (5.70) | (27.34) | (2,990.76) | (1,159.97) | (141.11) | — | — | — |
| — | 34.32% | 104.24% | 113.31% | (87.66%) | (39.45%) | 0.00% | 0.00% | 0.00% | |
| — | (824.63%) | (232.84%) | (882.09%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Return on Tangible Assets |
— | 61.36% | (207.40%) | (71.34%) | (30.38%) | (32.78%) | 0.00% | 0.00% | 0.00% |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (0.07) | (0.27) | (3,860.85) | (42.15) | (43.08) | 0.00 | 0.00 | 0.00 |
Cash per Share |
— | 0.03 | 0.17 | 5,163.72 | 126.47 | 116.50 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
— | (0.18) | 0.21 | 5,135.21 | 131.83 | 126.81 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.18) | 0.21 | 5,135.21 | 131.83 | 126.81 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
— | (2.66) | (9.85) | (36.29) | (69.14) | (85.14) | — | — | — |
Working Capital |
— | (6.84) | 5.35 | 38.90 | 204.25 | 223.83 | — | — | — |
Capital Expenditures |
— | — | (0.75) | (4.16) | (3.89) | (8.46) | — | — | — |
Net Current Asset Value |
— | (6.84) | 5.35 | 21.47 | 188.07 | 188.19 | — | — | — |
| Other line items | |||||||||
Quick Ratio |
— | 0.12 | 2.96 | 4.76 | 20.43 | 17.55 | — | — | — |
Depreciation/Fixed assets |
— | 0.28 | 0.13 | 0.06 | 0.20 | 0.16 | — | — | — |
Cash ROIC |
— | 192.97% | (69.86%) | (31.53%) | (15.65%) | (16.38%) | — | — | — |
Accounts Payable Turnover |
— | 0.05 | 0.25 | 0.91 | 2.28 | 5.40 | — | — | — |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 693.50 | 2,779.62 | 621.32 | 126.70 | 72.19 | — | — | — |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.07) | (0.27) | (3,860.85) | (42.15) | (43.08) | 0.00 | 0.00 | 0.00 |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
— | 0.37 | 0.37 | 1.53 | 1.95 | 1.66 | — | — | — |
Average Assets |
— | 0.50 | 5.42 | 4.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Common Equity |
— | (12.10) | (12.10) | (38.25) | 78.60 | 233.44 | — | — | — |
Columns are period end dates · fundamentals updated 5 Oct 2026